Self-Administered Low-Dose Inhaled Methoxyflurane (Penthrox) during Administration of OnabotulinumtoxinA for Chronic Migraines: A Real World Case Series
The intramuscular administration of onabotulinumtoxinA (onabotA) has been well established as an effective preventative treatment for chronic migraines (CM). Though generally well tolerated, the procedure-related pain can be a large limitation of the treatment for patients with comorbidities such as...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2019-03-01
|
| Series: | Canadian Journal of Pain |
| Online Access: | http://dx.doi.org/10.1080/24740527.2019.1591891 |